Cargando…

Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease

BACKGROUND: Non-traditional risk factors like inflammation and oxidative stress play an essential role in the increased cardiovascular disease (CVD) risk prevalent in chronic kidney disease (CKD). Tryptophan catabolism by the kynurenine pathway (KP) is linked to systemic inflammation and CVD in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Konje, Vetalise C, Rajendiran, Thekkelnaycke M, Bellovich, Keith, Gadegbeku, Crystal A, Gipson, Debbie S, Afshinnia, Farsad, Mathew, Anna V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173620/ https://www.ncbi.nlm.nih.gov/pubmed/34094518 http://dx.doi.org/10.1093/ckj/sfaa031

Ejemplares similares

Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease
por: Afshinnia, Farsad, et al.
Publicado: (2020)

Acetyl Co-A Carboxylase Inhibition Halts Hyperglycemia Induced Upregulation of De Novo Lipogenesis in Podocytes and Proximal Tubular Cells
por: Kayampilly, Pradeep, et al.
Publicado: (2022)

Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease
por: Benitez, Trista, et al.
Publicado: (2022)

Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort
por: Afshinnia, Farsad, et al.
Publicado: (2016)

Unsupervised machine learning for identifying important visual features through bag-of-words using histopathology data from chronic kidney disease
por: Lee, Joonsang, et al.
Publicado: (2022)

Clustering-based spatial analysis (CluSA) framework through graph neural network for chronic kidney disease prediction using histopathology images
por: Lee, Joonsang, et al.
Publicado: (2023)

Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2023)

Consent for Genetic Biobanking in a Diverse Multisite CKD Cohort
por: Troost, Jonathan P., et al.
Publicado: (2018)

Differential Attention Functioning in Pediatric Chronic Kidney Disease
por: Duquette, Peter J., et al.
Publicado: (2022)

Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes
por: Afshinnia, Farsad, et al.
Publicado: (2022)

Clinical predictors of neurocognitive deficits in children with chronic kidney disease
por: Slickers, Jennifer, et al.
Publicado: (2007)

The nervous system and chronic kidney disease in children
por: Gipson, Debbie S., et al.
Publicado: (2004)

The central nervous system in childhood chronic kidney disease
por: Gipson, Debbie S., et al.
Publicado: (2007)

Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy
por: Fort, Patrice E., et al.
Publicado: (2021)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
por: Swamy, Sowmya, et al.
Publicado: (2023)

Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease
por: Addi, Tawfik, et al.
Publicado: (2018)

Tryptophan: From Diet to Cardiovascular Diseases
por: Melhem, Nada Joe, et al.
Publicado: (2021)

Soluble ST2 and Galectin-3 and Progression of CKD
por: Alam, Mariam L., et al.
Publicado: (2018)

Depression and incident cardiovascular disease among patients with chronic kidney disease
por: D'Oro, Anthony, et al.
Publicado: (2023)

Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways
por: Afshinnia, Farsad, et al.
Publicado: (2013)

Focal segmental glomerulosclerosis in association with neurofibromatosis type 1: a case report and proposed molecular pathways
por: Afshinnia, Farsad, et al.
Publicado: (2013)

Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
por: Hruska, Keith, et al.
Publicado: (2011)

Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease
por: Cai, Jiashen, et al.
Publicado: (2023)

Addressing kidney health disparities with new national policy: the time is now
por: Walker, Claudia S., et al.
Publicado: (2023)

Brain abnormalities in children and adolescents with chronic kidney disease
por: Matsuda-Abedini, Mina, et al.
Publicado: (2018)

Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2021)

Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Nicholas, Susanne B., et al.
Publicado: (2022)

A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease
por: Spinale, Joann M., et al.
Publicado: (2014)

Microbiota-derived tryptophan metabolites in vascular inflammation and cardiovascular disease
por: Paeslack, Nadja, et al.
Publicado: (2022)

Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease
por: Kwiatkowska, Iwona, et al.
Publicado: (2020)

Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease
por: Arinze, Nkiruka V., et al.
Publicado: (2022)

Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation
por: Madella, Avra Melina, et al.
Publicado: (2022)

Effects of Prevalent and Incident Chronic Kidney Disease on Cardiovascular Events in Patients with Atrial Fibrillation
por: Lin, Hsuan-Yu, et al.
Publicado: (2019)

Author Correction: Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease
por: Ryu, Hyunjin, et al.
Publicado: (2021)

Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation
por: Obialo, Chamberlain I., et al.
Publicado: (2018)

Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes
por: Nichols, G. A., et al.
Publicado: (2010)

Cardiovascular disease in patients with chronic kidney disease
por: Wright, Julian, et al.
Publicado: (2009)

Altered HDL proteome predicts incident CVD in chronic kidney disease patients
por: Shao, Baohai, et al.
Publicado: (2021)

The Aryl Hydrocarbon Receptor-Activating Effect of Uremic Toxins from Tryptophan Metabolism: A New Concept to Understand Cardiovascular Complications of Chronic Kidney Disease
por: Sallée, Marion, et al.
Publicado: (2014)

Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers
por: Debnath, Subrata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u1ff82o5296d6vv3jttcva525k